Start for free
Start for free
Perceptive Advisors logo

Perceptive Advisors

North America, New York, United States, New York

Description

Perceptive Advisors is a privately owned hedge fund sponsor that finances the public equity markets across the globe.

Investor Profile

Perceptive Advisors has made 286 investments, with 29 in the past 12 months and 33% as lead.

Stage Focus

  • Post Ipo Equity (26%)
  • Series B (21%)
  • Series C (15%)
  • Series A (10%)
  • Series D (6%)
  • Series Unknown (6%)
  • Post Ipo Debt (5%)
  • Debt Financing (5%)
  • Series E (2%)
  • Private Equity (2%)

Country Focus

  • United States (85%)
  • United Kingdom (4%)
  • Canada (3%)
  • Israel (1%)
  • France (1%)
  • China (1%)
  • Germany (1%)
  • India (1%)
  • Belgium (1%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Therapeutics
  • Pharmaceutical
  • Life Science
  • Medical Device
  • Biopharma
  • Health Diagnostics
  • Genetics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Perceptive Advisors frequently co-invest with?

OrbiMed
OrbiMed
North America, New York, United States, New York
Co-Investments: 28
Surveyor Capital
Surveyor Capital
North America, Illinois, United States, Chicago
Co-Investments: 30
CA
Cormorant Asset Management
North America, Massachusetts, United States, Boston
Co-Investments: 29
Casdin Capital
Casdin Capital
North America, New York, United States, New York
Co-Investments: 26
RTW Investments
RTW Investments
North America, New York, United States, New York
Co-Investments: 32
T. Rowe Price
T. Rowe Price
North America, Maryland, United States, Baltimore
Co-Investments: 26
RA Capital Management
RA Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 56
Rock Springs Capital
Rock Springs Capital
North America, Maryland, United States, Baltimore
Co-Investments: 24
Redmile Group
Redmile Group
North America, California, United States, San Francisco
Co-Investments: 28
Janus Henderson Investors
Janus Henderson Investors
Europe, England, United Kingdom, London
Co-Investments: 24

Which angels does Perceptive Advisors often collaborate with?

RS
Randy Scott
North America, California, United States, San Francisco
Shared Deals: 1
PM
Peter Maag
North America, California, United States
Shared Deals: 2
ME
Martin Edwards
Europe, England, United Kingdom
Shared Deals: 1
AU
Anders Ullman
Europe, Hallands Lan, Sweden, Kungsbacka
Shared Deals: 1
Mark W. Hahn
Mark W. Hahn
North America, North Carolina, United States, Chapel Hill
Shared Deals: 1
AB
Arie Belldegrun
North America, California, United States, Los Angeles
Shared Deals: 2
VS
Vikas Sinha
North America, Massachusetts, United States, Boston
Shared Deals: 1
Daphne Teo
Daphne Teo
Asia, Singapore
Shared Deals: 1
David Zaccardelli
David Zaccardelli
North America, United States
Shared Deals: 1
DE
David Ebsworth
Europe, Zurich, Switzerland, Zürich
Shared Deals: 1

What are some of recent deals done by Perceptive Advisors?

Opus Genetics(formerly Ocuphire Pharma)

Farmington Hills, Michigan, United States

Ocuphire Pharma, a clinical-stage biopharmaceutical company, develops and commercializes therapies for patients with ophthalmic disorders.

BiopharmaBiotechnologyPharmaceutical
Post Ipo EquityMar 21, 2025
Amount Raised: $20,000,000
Solid Biosciences

Marlborough, Massachusetts, United States

Solid Biosciences is a life science company that conducts research for the treatment of Duchenne muscular dystrophy.

BiotechnologyGeneticsHealth CareMedical
Post Ipo EquityFeb 18, 2025
Amount Raised: $200,000,000
Kardigan

South San Francisco, California, United States

Kardigan is a patient-driven heart health firm that is revolutionizing cardiovascular drug development to produce medicines.

BiopharmaHealth CareMedical
Series AJan 10, 2025
Amount Raised: $300,000,000
Outset Medical

San Jose, California, United States

Outset Medical is a medical technology company that offers reimagining dialysis for patients and providers.

Health CareHealth DiagnosticsMedicalMedical Device
Post Ipo DebtJan 6, 2025
Amount Raised: $125,000,000
Rapt Therapeutics

South San Francisco, California, United States

Rapt is focused on the discovery and development of novel small-molecule agents to activate the immune system to eradicate cancer.

BiotechnologyHealth CareMedicalPharmaceuticalTherapeutics
Post Ipo EquityDec 23, 2024
Amount Raised: $150,000,000
Beta Bionics

Irvine, California, United States

Beta Bionics is a biotechnology company that provides software to reduce the burden of diabetes care.

BiotechnologyDiabetesMedical Device
Series ENov 13, 2024
Amount Raised: $60,000,000
Zucara Therapeutics

Vancouver, British Columbia, Canada

Zucara Therapeutics is developing the first once-daily therapeutic to prevent hypoglycemia (low blood sugar) in patients with diabetes.

BiotechnologyDiabetesPharmaceutical
Series BNov 12, 2024
Amount Raised: $20,000,000
Axonis Therapeutics

Boston, Massachusetts, United States

Axonis Therapeutics is a neuro-focused biotechnology company that focuses on the development of novel neuromedicines.

BiotechnologyLife ScienceMedical
Series AOct 30, 2024
Amount Raised: $115,000,000

Crescent Biopharma is a biotechnology firm focused on developing novel precision-engineered medicines.

BiotechnologyHealth CareMedical Device
UndisclosedOct 29, 2024
Amount Raised: $200,000,000
Inventiva Pharma

Daix, Bourgogne, France

Inventiva is a biopharmaceutical company with several drug candidates at clinical and preclinical stage.

BiopharmaBiotechnologyClinical TrialsMedicalMedical Device
Post Ipo EquityOct 14, 2024
Amount Raised: $126,004,765
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsPricing

Free tools

Pre-Money and Post-Money Valuation Calculator